Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引:2
|
作者
Groen, Kira [1 ,2 ]
Lechner-Scott, Jeannette [1 ,2 ]
Pohl, Daniela [3 ]
Levy, Michael [4 ]
Giovannoni, Gavin [5 ]
Hawkes, Chris [6 ]
机构
[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia
[2] Hunter New England Area Hlth, Newcastle, NSW, Australia
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England
[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England
关键词
WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;
D O I
10.1016/j.msard.2021.102931
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
    Abdelhak, Ahmed
    Antweiler, Kai
    Kowarik, Markus C.
    Senel, Makbule
    Havla, Joachim
    Zettl, Uwe K.
    Kleiter, Ingo
    Skripuletz, Thomas
    Haarmann, Axel
    Stahmann, Alexander
    Huss, Andre
    Gingele, Stefan
    Krumbholz, Markus
    Benkert, Pascal
    Kuhle, Jens
    Friede, Tim
    Ludolph, Albert C.
    Ziemann, Ulf
    Kuempfel, Tania
    Tumani, Hayrettin
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (02): : 477 - 485
  • [2] Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis
    Giarraputo, James
    Giamberardino, Stephanie
    Arvai, Stephanie
    Maichle, Sarah
    Eckstein, Christopher
    Newby, L. Kristin
    Gregory, Simon
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 354
  • [3] Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis
    Nicholas, AP
    Sambandam, T
    Echols, JD
    Tourtellotte, WW
    JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 473 (01) : 128 - 136
  • [4] Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis GFAP and DTI
    Saraste, Maija
    Bezukladova, Svetlana
    Matilainen, Markus
    Sucksdorff, Marcus
    Kuhle, Jens
    Leppert, David
    Airas, Laura
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 50
  • [5] Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum
    Vissers, JLM
    Mersch, MEC
    Rosmalen, CF
    van Heumen, MJMT
    van Geel, WJA
    Lamers, KJB
    Rosmalen, FMA
    Swinkels, LMJW
    Thomsen, J
    Herrmann, M
    CLINICA CHIMICA ACTA, 2006, 366 (1-2) : 336 - 340
  • [6] Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo
    Hainfellner, JA
    Voigtländer, T
    Ströbel, T
    Mazal, PR
    Maddalena, AS
    Aguzzi, A
    Budka, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 449 - 461
  • [7] Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
    Hogel, Heidi
    Rissanen, Eero
    Barro, Christian
    Matilainen, Markus
    Nylund, Marjo
    Kuhle, Jens
    Airas, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (02) : 210 - 219
  • [8] Serum Glial Fibrillary Acidic Protein: A Biomarker of Disease Progression in Multiple Sclerosis
    Barro, C.
    Healy, B.
    Liu, Y.
    Saxena, S.
    Paul, A.
    Polgar-Turcsanyi, M.
    Guttmann, C.
    Bakshi, R.
    Kropshofer, H.
    Weiner, H.
    Chitnis, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 154 - 154
  • [9] Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis
    Madill, Evan
    Healy, Brian C.
    Molazadeh, Negar
    Polgar-Turcsanyi, Mariann
    Glanz, Bonnie I.
    Weiner, Howard L.
    Chitnis, Tanuja
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2719 - 2730
  • [10] Neurofilament and glial fibrillary acidic protein in multiple sclerosis
    Norgren, N
    Sundström, P
    Svenningsson, A
    Rosengren, L
    Stigbrand, T
    Gunnarsson, M
    NEUROLOGY, 2004, 63 (09) : 1586 - 1590